GSK and Moderna Settle Patent Dispute Over COVID and RSV Shots
The companies settled GSK lawsuits alleging that Moderna’s Spikevax and mNEXSPIKE COVID-19 vaccines and mResvia RSV shot infringed its patents.
By Blake BrittainBritish drugmaker GSK LSE:GSK has settled lawsuits that accused Moderna's NASDAQ:MRNA COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Friday.